Saturday 17 October 2026
Export BHST’s income statement to Excel — free account
BioHarvest Sciences Inc.
BHST Consumer Defensive Packaged Foods
BioHarvest Sciences Inc.’s revenue for fiscal 2025 (year ended December 2025) was $34.5 million, up 37.0% from fiscal 2024. In the quarter to June 2026, revenue grew 3.78%, EPS grew 29.2%, free cash flow fell 64.0% and total debt fell 73.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
1.85
0.15
+8.82%
Follow BHST
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Apr '19 | Dec '18 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 6 | 5 | 4 | 5 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Altman Z-Score |
0.33 | (3.08) | (9.03) | (10.73) | 2.41 | (16.71) | (48.60) | — | — |
P/S ratio |
2.77 | 3.97 | 5.98 | 17.23 | 74.69 | 4.42 | 0.00 | — | — |
Altman Z″-Score (non-manufacturers) |
(3.80) | (16.07) | (30.75) | (37.65) | (22.49) | (38.36) | (160.29) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Beneish M-Score |
(2.41) | (2.08) | (0.72) | (3.11) | (0.53) | (4.60) | — | — | — |
P/Operating CF |
(42.43) | (41.89) | (25.31) | (37.83) | (68.68) | (1.40) | (0.38) | — | — |
P/B ratio |
3.75 | 75.25 | 0.00 | 0.00 | 54.99 | 0.00 | 0.07 | — | — |
Price to Tangible BV |
3.75 | 75.25 | 0.00 | 0.00 | 54.99 | 0.00 | 0.07 | — | — |
EV/Sales |
2.18 | 4.03 | 7.18 | 18.47 | 72.73 | (0.07) | 0.00 | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
EV/Operating CF |
(10.39) | (15.20) | (10.67) | (10.99) | (22.50) | 0.01 | 0.11 | — | — |
EV/FCF |
(7.84) | (10.67) | (9.10) | (9.67) | (18.13) | 0.01 | 0.11 | — | — |
Quick Ratio |
3.38 | 0.29 | 0.25 | 0.26 | 1.62 | 1.13 | 0.05 | 19.70 | 19.70 |
Current Ratio |
3.97 | 0.55 | 0.34 | 0.38 | 1.94 | 1.18 | 0.05 | 32.15 | 32.15 |
Net Debt/EBITDA |
5.18 | (0.26) | (1.66) | (0.69) | 0.51 | 0.30 | (11.36) | 0.12 | 0.12 |
Debt/Assets |
5.39% | 15.62% | 136.87% | 91.01% | 0.00% | 0.00% | 1,160.88% | 0.00% | 0.00% |
Debt/Equity |
0.10 | 2.94 | (1.38) | (1.44) | 0.00 | 0.00 | (0.87) | 0.00 | 0.00 |
Asset Turnover |
0.95 | 1.26 | 1.04 | 0.56 | 0.27 | 0.11 | 0.06 | 0.00 | — |
Operating CF/Net income |
0.65 | 0.52 | 0.68 | 0.82 | 0.69 | 0.59 | 0.45 | 0.33 | 0.00 |
Capex/Depreciation |
(1.45) | (2.27) | (1.75) | (1.76) | (4.22) | (0.60) | (0.10) | — | — |
Interest Coverage |
(1.01) | (1.18) | (3.80) | (7.15) | (5.22) | (10.09) | (0.61) | (5.58) | (5.58) |
| (83.17%) | 190.98% | 120.91% | 731.03% | (3,509.64%) | 45.00% | 45.67% | 721.71% | 0.00% | |
| (30.65%) | (64.56%) | (103.00%) | (114.65%) | (126.70%) | (179.74%) | (138.88%) | (91.29%) | 0.00% | |
ROIC |
(69.80%) | (153.54%) | (1,916.54%) | (750.28%) | 0.00% | 0.00% | 0.00% | (85.46%) | (85.46%) |
Return on Tangible Assets |
(35.76%) | (957.94%) | 93.14% | 490.87% | (138.29%) | (201.59%) | 21.61% | (610.58%) | (610.58%) |
Average Days of Receivables |
30.84 | 26.24 | 35.46 | 80.20 | 107.66 | 326.29 | 470.48 | — | — |
Research and Development Expense of Revenue |
15.39% | 19.04% | 26.59% | 41.98% | 196.43% | 319.19% | 617.43% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
60.10% | 64.05% | 96.51% | 173.21% | 239.39% | 1,121.46% | 455.50% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1.73% | 2.39% | 4.44% | 24.59% | 160.18% | 349.24% | 209.17% | 0.00% | — |
Graham Net Nets |
0.09 | (0.16) | (0.27) | (0.12) | (0.01) | (3.06) | 3.13 | — | — |
Graham Number |
0.00 | 0.00 | 4.79 | 2.96 | 0.00 | 1.90 | 0.00 | — | — |
Earnings Yield |
(11.75%) | (13.73%) | (16.58%) | (11.86%) | (6.26%) | (376.22%) | (1,065.00%) | — | — |
Free Cash Flow Yield |
(10.03%) | (9.51%) | (13.19%) | (11.08%) | (5.37%) | (231.29%) | (870.49%) | — | — |
Revenue per Share |
1.87 | 1.56 | 0.94 | 0.42 | 0.17 | 0.04 | 0.07 | 0.00 | — |
Operating CF per Share |
(0.39) | (0.41) | (0.63) | (0.71) | (0.55) | (0.40) | (0.81) | (1.03) | — |
Capex per Share |
(0.13) | (0.18) | (0.11) | (0.10) | (0.13) | (0.02) | (0.01) | 0.00 | — |
Free Cash Flow per Share |
(0.52) | (0.59) | (0.74) | (0.80) | (0.68) | (0.42) | (0.82) | (1.03) | — |
Cash per Share |
1.25 | 0.15 | 0.40 | 0.13 | 0.33 | 0.18 | 0.31 | 0.33 | 0.00 |
Shareholders Equity per Share |
1.38 | 0.08 | (1.10) | (0.45) | 0.23 | (0.24) | (9.13) | 2.28 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.38 | 0.08 | (1.10) | (0.45) | 0.23 | (0.24) | (9.13) | 2.28 | 0.00 |
Free Cash Flow |
(9.58) | (9.52) | (10.00) | (10.50) | (8.43) | (4.05) | (2.42) | (1.69) | — |
Working Capital |
22.82 | (6.40) | (17.41) | (7.20) | 2.74 | 0.34 | (25.22) | 0.84 | 0.84 |
Capital Expenditures |
(2.35) | (2.83) | (1.47) | (1.26) | (1.64) | (0.17) | (0.03) | — | — |
Net Current Asset Value |
8.28 | (15.81) | (20.80) | (11.00) | (1.69) | (5.36) | (27.75) | (1.04) | (1.04) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
0.07 | 0.11 | 0.12 | 0.23 | 0.78 | 0.44 | 0.16 | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.20 | 0.16 | 0.21 | 0.15 | 0.09 | 0.10 | 0.50 | — | — |
Cash ROIC |
(18.77%) | (124.84%) | (90.58%) | (240.98%) | (120.97%) | 790.63% | 93.46% | (39.73%) | 0.00% |
Accounts Receivable Turnover |
14.60 | 16.56 | 10.39 | 6.02 | 4.32 | 1.25 | 0.00 | — | — |
Accounts Payable Turnover |
4.56 | 4.24 | 4.95 | 4.41 | 2.19 | 0.74 | 1.32 | — | — |
Inventory Turnover |
3.42 | 3.67 | 3.66 | 3.71 | 2.79 | 3.42 | 0.00 | — | — |
Average Days of Payables |
68.33 | 114.41 | 92.20 | 91.02 | 223.03 | 615.41 | 502.12 | 0.00 | — |
Days of Inventory on Hand |
118.59 | 118.63 | 127.87 | 117.54 | 236.54 | 141.47 | 98.49 | — | — |
Average Receivables |
2.36 | 1.52 | 1.22 | 0.91 | 0.49 | 0.32 | — | — | — |
Average Payables |
3.08 | 2.65 | 1.42 | 0.97 | 0.66 | 0.35 | 0.14 | — | — |
Average Inventory |
4.11 | 3.06 | 1.92 | 1.15 | 0.51 | 0.08 | — | — | — |
Average Assets |
36.33 | 20.00 | 12.20 | 9.80 | 7.76 | 3.66 | 3.82 | 5.63 | — |
Average Common Equity |
13.39 | (6.76) | (10.39) | (1.54) | 0.28 | (14.63) | (11.63) | (0.71) | — |
Columns are period end dates